Michelle Asinobi

Michelle Asinobi is a skilled research professional with a strong background in protein sciences and analytical techniques. Currently serving as a Research Associate II at Pheast Therapeutics, Michelle previously held roles at Alector, where responsibilities included pre-validation of IgG1 using Size Exclusion High-Performance Liquid Chromatography and optimization of SE-HPLC testing for monoclonal antibodies. At Alector, Michelle also contributed to upstream process development by monitoring and cultivating CHO cell subclones. Prior experience includes roles at BioCurious, Cepheid, and various positions at the University of Hawaii at Manoa, emphasizing community outreach and support in health initiatives. Michelle holds a Bachelor of Arts in Public Health from the University of Hawaii at Manoa.